Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Biological Marker
33%
Biopsy Technique
10%
Cell Cycle
6%
Cell Cycle Regulation
6%
Cell-Free DNA
71%
Cerebrospinal Fluid
7%
Childhood Cancer
6%
CHRNA3
6%
Circulating Tumor DNA
20%
Droplet Digital Polymerase Chain Reaction
53%
Event Free Survival
10%
Ewing Sarcoma
13%
Fusion Gene
12%
Ganglioneuroblastoma
64%
Gene Dosage
6%
Hodgkin's Lymphoma
5%
Intracranial Tumor
8%
Invasive Diagnostics
6%
Kidney Tumour
7%
Liquid Biopsy
93%
Localized Disease
6%
Malignant Neoplasm
6%
Messenger RNA
23%
Metastatic Carcinoma
16%
Minimal Residual Disease
9%
Morbidity
6%
Neoplasm
68%
Nucleic Acid
6%
Osteosarcoma
5%
Patient with Neuroblastoma
30%
Pediatric Cancer
30%
Pediatrics
100%
Pediatrics Patient
8%
Platelet
6%
Reduced Representation Bisulfite Sequencing
10%
Reverse Transcriptase
13%
Rhabdomyosarcoma
58%
Size-Exclusion Chromatography
13%
Solid Malignant Neoplasm
60%
Specific Tumor
8%
Thrombocyte Poor Plasma
6%
Treatment Response
9%
Tumor
10%
Tumor Marker
10%
Tumor Suppressor Gene
5%
Whole Genome Sequencing
10%
Wilms' Tumor
13%
Keyphrases
Bone Marrow
6%
Cell-free
6%
Cell-free DNA (cfDNA)
42%
Circulating Tumor DNA (ctDNA)
20%
Copy number Alterations
6%
Diagnostic Biomarker
20%
DNA Breakpoint
6%
Droplet Digital PCR (ddPCR)
39%
Event-free Survival
6%
Ewing Sarcoma
10%
Fusion Gene
12%
Large Cohort
6%
Liquid Biopsy
80%
Material Reference
20%
Minimally Invasive Biomarkers
5%
Molecular Characterization
20%
Mouse Model
10%
Multiplex Droplet Digital PCR
8%
Neuroblastoma
16%
Patient-specific
20%
Pediatric Rhabdomyosarcoma
40%
Pediatric Tumors
80%
Plasma Diagnostics
6%
Plasma Samples
22%
Prognostic Biomarker
20%
Quantitative PCR
6%
RASSF1A
40%
Reduced Representation Bisulfite Sequencing
6%
Region of Interest
8%
Rhabdomyosarcoma
40%
RNA Panel
9%
Routinely Collected
20%
Specific Marker
12%
Targeted Locus Amplification
20%
Treatment Response
5%
Tumor
8%
Tumor Burden
6%
Tumor DNA
6%
Tumor Subtype
6%
Tumor-derived
16%
Tumor-specific
8%
Ultrasound Enhancement
20%
Working Diagnosis
15%
